Phathom Pharmaceuticals, Inc.

PHAT · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$135,156$149,569$212,315$297,263
Short-Term Investments$0$0$0$0
Receivables$55,789$51,255$36,364$38,797
Inventory$3,611$3,431$3,166$3,208
Other Curr. Assets$13,227$14,620$13,055$20,866
Total Curr. Assets$207,783$218,875$264,900$360,134
Property Plant & Equip (Net)$3,850$2,115$1,742$2,089
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$2,862$2,862$2,862$2,862
Tax Assets$0$0$0$150
Other NC Assets$25,794$26,368$24,704$13,233
Total NC Assets$32,506$31,345$29,308$18,334
Other Assets$0$0$0$0
Total Assets$240,289$250,220$294,208$378,468
Liabilities
Payables$1,075$4,008$11,617$10,507
Short-Term Debt$591$22,002$17,584$20,278
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$91,457$65,813$44,831$54,943
Total Curr. Liab.$93,123$91,823$74,032$85,728
LT Debt$2,123$552,731$547,052$534,670
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$150
Other NC Liab.$567,577$11,500$11,500$11,500
Total NC Liab.$569,700$564,231$558,552$546,320
Other Liabilities$0$0$0$0
Cap. Leases$0$827$316$0
Total Liabilities$662,823$656,054$632,584$632,048
Equity
Pref Stock$0$0$0$0
Common Stock$6$6$6$6
Retained Earnings-$1,463,110-$1,433,137-$1,357,327-$1,263,011
AOCI$0$0$0$0
Other Equity$1,040,570$1,027,297$1,018,945$1,009,425
Total Equity-$422,534-$405,834-$338,376-$253,580
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$240,289$250,220$294,208$378,468
Net Debt-$132,442$425,164$352,321$257,685
Phathom Pharmaceuticals, Inc. (PHAT) Financial Statements & Key Stats | AlphaPilot